Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. Long Term Debt 2010–2025
Lifecore Biomedical, Inc. annual long term debt history from 2011 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Lifecore Biomedical, Inc. long term debt as of May 25, 2025: 130.4M, a 4.63% increase year-over-year.
- Lifecore Biomedical, Inc. long term debt for 2025 were 130.4M, a 4.63% increase from 2024.
- Lifecore Biomedical, Inc. long term debt for 2024 were 124.7M, a 46.95% increase from 2023.
- Lifecore Biomedical, Inc. long term debt for 2023 were 84.8M, a 13.59% decrease from 2022.
- Lifecore Biomedical, Inc. long term debt for 2022 were 98.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lifecore Biomedical, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $130 |
| 2024 | $125 |
| 2023 | $85 |
| 2022 | $98 |
| 2021 | $165 |
| 2020 | $113 |
| 2019 | $97 |
| 2018 | $42 |
| 2017 | $47 |
| 2016 | $54 |
| 2015 | $43 |
| 2014 | $34 |
| 2013 | $40 |
| 2012 | $47 |
| 2011 | $16 |
Lifecore Biomedical, Inc. Long Term Debt — FAQ
Lifecore Biomedical, Inc. (LFCR) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LFCR's long term debt history?
The chart and table above show Lifecore Biomedical, Inc.'s long term debt by year and by quarter, including the growth rate.